Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


INTERWEST PARTNERS VII L P Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2012 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
02/07/2011 4 INTERWEST PARTNERS VII L P (Former 10% Owner) has filed a Form 4 on EPOCRATES INC
Txns: Converted 1,315,803 shares @ $0
Converted 711,602 shares @ $0
Converted 265,120 shares @ $0
Sold 407,401 shares @ $16, valued at $6.5M
Converted 59,696 shares @ $0
Converted 34,005 shares @ $0
Converted 12,208 shares @ $0
Sold 18,822 shares @ $16, valued at $301.2k
Converted 1,674,050 convertible preferred @ $0
Converted 75,950 convertible preferred @ $0
Converted 783,587 convertible preferred @ $0
02/01/2011 3 Form 3 - Initial statement of beneficial ownership of securities
02/13/2009 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
05/06/2008 SC 13G/A INTERWEST PARTNERS VII L P has filed a Schedule 13D for METABASIS THERAPEUTICS, INC
04/18/2008 4 INTERWEST PARTNERS VII L P (10% Owner) has filed a Form 4 on METABASIS THERAPEUTICS INC
Txns: Bought 945,577 shares @ $2.34, valued at $2.2M
Bought 45,239 shares @ $2.34, valued at $105.9k
Unknown transaction of 118,759 warrants @ $8.694, valued at $1M
Unknown transaction of 142,493 warrants @ $6.74, valued at $960.4k
Unknown transaction of 5,687 warrants @ $8.694, valued at $49.4k
Unknown transaction of 6,824 warrants @ $6.74, valued at $46k
Bought 118,759 warrants @ $2.34, valued at $277.9k
Bought 142,493 warrants @ $2.34, valued at $333.4k
Bought 5,687 warrants @ $2.34, valued at $13.3k
Bought 6,824 warrants @ $2.34, valued at $16k
Exercised (in-or-at-the-money) 118,759 warrants @ $2.34, valued at $277.9k
02/12/2008 SC 13G/A INTERWEST PARTNERS VII L P has filed a Schedule 13D for METABASIS THERAPEUTICS, INC
02/14/2007 SC 13G/A INTERWEST PARTNERS VII L P has filed a Schedule 13D for METABASIS THERAPEUTICS, INC.
02/14/2007 SC 13G/A INTERWEST PARTNERS VII L P has filed a Schedule 13D for ASPREVA PHARMACEUTICALS CORPORATION
02/14/2006 SC 13G/A INTERWEST PARTNERS VII L P has filed a Schedule 13D for METABASIS THERAPEUTICS, INC
02/14/2006 SC 13G INTERWEST PARTNERS VII L P has filed a Schedule 13D for ASPREVA PHARMACEUTICALS CORPORATION
10/04/2005 4 INTERWEST PARTNERS VII L P (10% Owner) has filed a Form 4 on METABASIS THERAPEUTICS INC
Txns: Bought 407,124 shares @ $5.86, valued at $2.4M
Bought 19,497 shares @ $5.86, valued at $114.3k
Bought 142,493 warrants @ $6.74, valued at $960.4k
Bought 6,824 warrants @ $6.74, valued at $46k
02/09/2005 SC 13G INTERWEST PARTNERS VII L P reports a 14.4% stake in METABASIS THERAPEUTICS, INC
06/23/2004 4 INTERWEST PARTNERS VII L P (10% Owner) has filed a Form 4 on METABASIS THERAPEUTICS INC
Txns: Converted 1,979,270 shares @ $0
Converted 94,782 shares @ $0
Bought 124,059 shares @ $7, valued at $868.4k
Bought 5,941 shares @ $7, valued at $41.6k
Converted 782,411 convertible preferred @ $0
Converted 37,468 convertible preferred @ $0
Converted 539,815 convertible preferred @ $0
Converted 25,850 convertible preferred @ $0
Converted 657,044 convertible preferred @ $0
Converted 31,464 options to buy @ $0
06/23/2004 4 INTERWEST PARTNERS VII L P (10% Owner) has filed a Form 4 on METABASIS THERAPEUTICS INC
Txns: Converted 1,979,270 shares @ $0
Converted 94,782 shares @ $0
Bought 124,059 shares @ $7, valued at $868.4k
Bought 5,941 shares @ $7, valued at $41.6k
Converted 782,411 convertible preferred @ $0
Converted 37,468 convertible preferred @ $0
Converted 539,815 convertible preferred @ $0
Converted 25,850 convertible preferred @ $0
Converted 657,044 convertible preferred @ $0
Converted 31,464 convertible preferred @ $0
02/11/2002 SC 13G/A INTERWEST PARTNERS VII L P reports a 3.4% stake in Inspire Pharmaceuticals, Inc.
02/12/2001 SC 13G INTERWEST PARTNERS VII L P reports a 6.7% stake in Inspire Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy